Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate
- 31 August 2011
- journal article
- research article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 103 (4), 323-329
- https://doi.org/10.1016/j.ymgme.2011.04.013
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia controlMolecular Genetics and Metabolism, 2010
- Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosisHepatology, 2010
- Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21‐year, multicentre study of acute hyperammonaemic episodesActa Paediatrica, 2008
- Cross-sectional multicenter study of patients with urea cycle disorders in the United StatesMolecular Genetics and Metabolism, 2008
- Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle DisordersNew England Journal of Medicine, 2007
- Urea Cycle Disorders: Diagnosis, Pathophysiology, and TherapyAdvances in Pediatrics, 1996
- A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.1994
- Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiencyMetabolism, 1993
- Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen ExcretionPediatric Research, 1991
- Treatment of Inborn Errors of Urea SynthesisNew England Journal of Medicine, 1982